MeiraGTx Holdings plc financial data

Symbol
MGTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
450 East 29 Th Street, 15 Th Floor, New York, New York
State of incorporation
Cayman Islands
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 232 % +24.4%
Debt-to-equity 171 % +1.6%
Return On Equity -86.3 % +21.3%
Return On Assets -31.9 % +22.1%
Operating Margin -2.01K % -923%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 64.9M shares +9.01%
Common Stock, Shares, Outstanding 64.7M shares +8.65%
Entity Public Float 260M USD +7.12%
Common Stock, Value, Issued 3K USD +50%
Weighted Average Number of Shares Outstanding, Basic 64.4M shares +16.3%
Weighted Average Number of Shares Outstanding, Diluted 64.4M shares +16.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 282K USD -92%
Revenue from Contract with Customer, Excluding Assessed Tax 6.69M USD -84.2%
Research and Development Expense 131M USD +61.7%
General and Administrative Expense 46.5M USD -6.78%
Operating Income (Loss) -169M USD -36%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -93.1M USD +25.2%
Earnings Per Share, Basic -1.42 USD/shares +44.5%
Earnings Per Share, Diluted -1.42 USD/shares +44.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 100M USD +7.76%
Accounts Receivable, after Allowance for Credit Loss, Current 1.63M USD -95%
Other Assets, Current 660K USD -57.3%
Assets, Current 111M USD -22.6%
Other Long-term Investments 1.5M USD 0%
Property, Plant and Equipment, Net 109M USD -4.53%
Operating Lease, Right-of-Use Asset 13.8M USD -26.1%
Intangible Assets, Net (Excluding Goodwill) 969K USD -22.6%
Other Assets, Noncurrent 1.14M USD -22.3%
Assets 267M USD -14.1%
Accounts Payable, Current 21.4M USD -24.9%
Accrued Liabilities, Current 16.9M USD -32%
Liabilities, Current 47M USD -34.5%
Deferred Income Tax Liabilities, Net 184K USD +7.6%
Operating Lease, Liability, Noncurrent 10.7M USD -31.1%
Liabilities 187M USD -0.07%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.61M USD -413%
Retained Earnings (Accumulated Deficit) -623M USD -17.6%
Stockholders' Equity Attributable to Parent 80M USD -35.2%
Liabilities and Equity 267M USD -14.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -36.7M USD +1.74%
Net Cash Provided by (Used in) Financing Activities -1.27M USD -3.17%
Net Cash Provided by (Used in) Investing Activities 27.3M USD
Common Stock, Shares Authorized 1.29B shares 0%
Common Stock, Shares, Issued 64.7M shares +8.65%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 101M USD +8.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.95M USD +87.9%
Deferred Tax Assets, Valuation Allowance 126M USD +8.31%
Deferred Tax Assets, Gross 131M USD +4.83%
Operating Lease, Liability 14.9M USD -24.1%
Payments to Acquire Property, Plant, and Equipment 1.68M USD -80.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -97.9M USD +24.7%
Lessee, Operating Lease, Liability, to be Paid 17.4M USD -27.6%
Property, Plant and Equipment, Gross 149M USD +15.1%
Operating Lease, Liability, Current 4.21M USD +2.08%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.49M USD -1.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.68M USD -5.96%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.48M USD -43.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.58M USD +1.44%
Deferred Tax Assets, Operating Loss Carryforwards 70.7M USD -4.98%
Unrecognized Tax Benefits 2.03M USD +117%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.61M USD -69.3%
Operating Lease, Payments 5.69M USD +3.87%
Additional Paid in Capital 707M USD +8.34%
Depreciation, Depletion and Amortization 3.28M USD +5.92%
Share-based Payment Arrangement, Expense 26.8M USD -2.41%
Interest Expense 13.3M USD +19%